Presentation is loading. Please wait.

Presentation is loading. Please wait.

Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma  Arianna Barbetta, MD, Francisco Schlottmann, MD, Tamar Nobel, MD, David B.

Similar presentations


Presentation on theme: "Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma  Arianna Barbetta, MD, Francisco Schlottmann, MD, Tamar Nobel, MD, David B."— Presentation transcript:

1 Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma 
Arianna Barbetta, MD, Francisco Schlottmann, MD, Tamar Nobel, MD, David B. Sewell, MA, Meier Hsu, MS, Kay See Tan, PhD, Hans Gerdes, MD, Pari Shah, MD, Manjit S. Bains, MD, Matthew Bott, MD, James M. Isbell, MD, David R. Jones, MD, Daniela Molena, MD  The Annals of Thoracic Surgery  Volume 106, Issue 1, Pages (July 2018) DOI: /j.athoracsur Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Three-year and 5-year overall survival for patients with (N+) and without (N−) nodal disease. (CI = confidence interval; OS = overall survival.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Three-year and 5-year recurrence-free survival for patients with (N+) and without (N−) nodal disease. (CI = confidence interval; RFS = recurrence-free survival.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions


Download ppt "Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma  Arianna Barbetta, MD, Francisco Schlottmann, MD, Tamar Nobel, MD, David B."

Similar presentations


Ads by Google